---
title: "U.S. stock market midday update: Trinity Biotech-A rises 24.59%, influx of funds drives volatility"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294084436.md"
description: "Trinity Biotech-A rose 24.59%; Intuitive Surgical rose 2.79%, with a transaction volume of USD 508 million; Medtronic rose 4.42%, with a transaction volume of USD 473 million; Abbott rose 3.73%, with a transaction volume of USD 394 million; Stryker rose 3.40%, with a market value of USD 133.5 billion"
datetime: "2026-07-28T14:53:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294084436.md)
  - [en](https://longbridge.com/en/news/294084436.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294084436.md)
---

# U.S. stock market midday update: Trinity Biotech-A rises 24.59%, influx of funds drives volatility

**U.S. Stock Market Midday Update**

Trinity Biotech-A rose 24.59%, with increased trading volume and no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

**Stocks with High Trading Volume in the Industry**

Intuitive Surgical rose 2.79%. Based on recent key news:

1.  On July 28, UBS initiated coverage on the medical technology sector, giving Intuitive Surgical a "Buy" rating with a target price of $500. UBS is optimistic about Intuitive Surgical's growth potential in automation and new surgical fields, driving the stock price up.
    
2.  On July 27, Intuitive Surgical partnered with Deion “Coach Prime” Sanders to raise patient awareness of surgical options. This move helps enhance the company's brand influence and market demand, promoting the stock price increase.
    
3.  On July 28, analysts maintained an optimistic view on Intuitive Surgical, despite a significant recent drop in stock price. Analysts believe the company has enormous future sales growth potential, boosting market confidence. The medical technology sector has performed strongly recently, with evident capital inflow.
    

Medtronic rose 4.42%. Based on recent key news:

1.  On July 28, UBS began tracking Medtronic, giving it a Buy rating with a target price of $100. This move has strengthened market confidence in Medtronic, driving the stock price up.
    
2.  On July 28, Evercore ISI Group analyst Vijay Kumar maintained Medtronic's Outperform rating but lowered the target price from $106 to $105. Although the target price was slightly reduced, maintaining the Outperform rating still has a positive impact on the stock price.
    
3.  On July 28, Medtronic announced it would release its first-quarter financial report on September 1. The market expects the report to show positive financial performance, further driving the stock price up. The medical device industry has performed strongly recently, with evident capital inflow.
    

Abbott rose 3.73%. Based on recent key news:

1.  On July 27, Abbott announced that its SimpleScreen™ CRC blood screening test received FDA approval and will be commercialized by Abbott in the U.S. This news drove the stock price up. Source: Reuters
    
2.  On July 25, a federal judge dismissed a shareholder lawsuit against Abbott related to the 2022 infant formula recall incident. This news alleviated investor concerns and boosted the stock price. Source: Reuters
    
3.  On July 28, UBS lowered Abbott's target stock price from $135 to $125, but analysts still gave Abbott a "Moderate Buy" rating. This news had a limited impact on the stock price. Source: MarketBeat The healthcare industry has performed strongly recently, with widespread applications of AI technology **Stocks Ranked Among the Top by Market Capitalization in the Industry**
    

Stryker rose 3.40%. Based on recent key news:

1.  On July 28, the weight of the healthcare sector in the S&P 500 index fell to a historic low, prompting investors to seek stability and quality, which drove up Stryker's stock price. Source: Simply Wall St
    
2.  No other significant news recently. The decline in the healthcare sector's weight has led investors to focus on stability

### Related Stocks

- [TRIB.US](https://longbridge.com/en/quote/TRIB.US.md)
- [ISRG.US](https://longbridge.com/en/quote/ISRG.US.md)
- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [SYK.US](https://longbridge.com/en/quote/SYK.US.md)

## Related News & Research

- [Trinity Biotech says trial data show CGM+ detects nocturnal compression false lows](https://longbridge.com/en/news/291547650.md)
- [Healthcare of Ontario Pension Plan Trust Fund Invests $2.25 Million in Harmony Gold Mining Company Limited $HMY](https://longbridge.com/en/news/294579460.md)
- [Niche brands are finding online reach through Sam's Club](https://longbridge.com/en/news/294670100.md)
- [Segall Bryant & Hamill LLC Takes $17.54 Million Position in Kilroy Realty Corporation $KRC](https://longbridge.com/en/news/294602942.md)
- [GKV Capital Management Co. Inc. Takes Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/294577517.md)